Aflac (AFL) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$18.1B

Revenue (quarter)

$4.1B

Revenue growth (year over year)

−1.03%

Gross profit (trailing twelve months)

—

Gross margin

—

Net income (trailing twelve months)

$4.9B

Net income (quarter)

$825.0M

Net income growth (year over year)

+37.73%

Net margin

26.91%

Return on equity

16.91%

EPS (trailing twelve months)

$9.31

Book value per share

$60.35

P/E (trailing twelve months)

11.95

Price to book

1.92

Debt to assets

73.86%

Payout ratio

34.14%

Dividend yield

2.13%

Company profile

Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments: Aflac Japan, which generates the maximum revenue, and Aflac U.S.

• Is Aflac (AFL) profitable?

  Yes. Aflac earned $4.9B in net income over the trailing twelve months, a net margin of 26.91%.

• How much revenue does Aflac (AFL) make?

  Aflac generated $18.1B in revenue over the trailing twelve months, down 1.03% year over year.

• What is AFL's P/E ratio?

  Aflac trades at 11.9 times trailing twelve-month earnings, on an EPS of $9.31.

• How do I buy stock in Aflac (AFL)?

  AFL trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.